Robert Benamouzig

Summary

Country: France

Publications

  1. ncbi Identification and chemoprevention in subjects at moderate risk of colorectal cancer
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, 125 rue de Stalingrad, Bobigny, France
    Best Pract Res Clin Gastroenterol 25:631-40. 2011
  2. ncbi Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, Paris 13 University, Bobigny, France
    Gut 61:255-61. 2012
  3. ncbi Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Hopital Avicenne, 125 route de Stalingrad, Bobigny, France
    Gut 59:622-9. 2010
  4. ncbi Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer
    Robert Benamouzig
    Department of Gastro enterology, Hopital Avicenne, 125 rue de Stalingrad, 93009 Bobigny Cedex, France
    Curr Top Med Chem 5:493-503. 2005
  5. ncbi Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP-HP, Paris 13 University, Bobigny Cedex, France
    Gastroenterology 125:328-36. 2003
  6. ncbi Calcium supplementation for preventing colorectal cancer: where do we stand?
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, 93009 Bobigny Cedex, France
    Lancet 364:1197-9. 2004
  7. ncbi [NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]
    Gaetan des Guetz
    Service d Oncologie Medicale, Hopital Avicenne, Bobigny, France
    Gastroenterol Clin Biol 29:411-4. 2005
  8. ncbi Is colorectal cancer an avoidable disease nowadays?
    Robert Benamouzig
    Department of Gastroenterology, Hopital Avicenne, 125 route de Stalingrad, 93000 Bobigny, France
    Best Pract Res Clin Gastroenterol 18:107-11. 2004
  9. ncbi Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy
    Michael Soussan
    Department of Nuclear Medicine, Universite Paris 13, CHU Avicenne, 125 rue de Stalingrad, 93000, Bobigny, France
    Eur Radiol 22:1479-87. 2012
  10. ncbi Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery
    Marinos Fysekidis
    Diabetes, Nutrition and Endocrinology Department, Avicenne Hospital, Bobigny, France
    Obes Surg 22:403-10. 2012

Detail Information

Publications10

  1. ncbi Identification and chemoprevention in subjects at moderate risk of colorectal cancer
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, 125 rue de Stalingrad, Bobigny, France
    Best Pract Res Clin Gastroenterol 25:631-40. 2011
    ..In the present article, we will try to better define these particular situations and discuss the risk quantification and the expected chemoprevention contribution...
  2. ncbi Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, Paris 13 University, Bobigny, France
    Gut 61:255-61. 2012
    ..In this study the results of daily intake of low-dose aspirin on polyp recurrence at 4-year follow-up are presented...
  3. ncbi Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Hopital Avicenne, 125 route de Stalingrad, Bobigny, France
    Gut 59:622-9. 2010
    ..Low-dose aspirin reduces the incidence of colorectal cancer and recurrence of adenomas. Cyclooxygenase-2 (COX-2), one of its main target enzymes, is reportedly over-expressed in colorectal adenomas...
  4. ncbi Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer
    Robert Benamouzig
    Department of Gastro enterology, Hopital Avicenne, 125 rue de Stalingrad, 93009 Bobigny Cedex, France
    Curr Top Med Chem 5:493-503. 2005
    ..Four RCTs of the effect of aspirin on adenoma recurrence are available. Other trials are currently underway...
  5. ncbi Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP-HP, Paris 13 University, Bobigny Cedex, France
    Gastroenterology 125:328-36. 2003
    ..01), and initial adenomatous polyp burden less than 10 mm (P = 0.001). CONCLUSIONS: Daily soluble aspirin is associated with a reduction in the risk for recurrent adenomas found at colonoscopy 1 year after starting treatment...
  6. ncbi Calcium supplementation for preventing colorectal cancer: where do we stand?
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, 93009 Bobigny Cedex, France
    Lancet 364:1197-9. 2004
  7. ncbi [NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]
    Gaetan des Guetz
    Service d Oncologie Medicale, Hopital Avicenne, Bobigny, France
    Gastroenterol Clin Biol 29:411-4. 2005
  8. ncbi Is colorectal cancer an avoidable disease nowadays?
    Robert Benamouzig
    Department of Gastroenterology, Hopital Avicenne, 125 route de Stalingrad, 93000 Bobigny, France
    Best Pract Res Clin Gastroenterol 18:107-11. 2004
    ..Chemoprevention of colorectal cancer that involves the long-term use of pharmacological agents as aspirin also seems to be effective...
  9. ncbi Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy
    Michael Soussan
    Department of Nuclear Medicine, Universite Paris 13, CHU Avicenne, 125 rue de Stalingrad, 93000, Bobigny, France
    Eur Radiol 22:1479-87. 2012
    ..To assess the accuracy of FDG-PET/CT and MR with diffusion-weighted imaging (MR-DWI) for diagnosing peritoneal carcinomatosis (PC) from gastrointestinal malignancies...
  10. ncbi Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery
    Marinos Fysekidis
    Diabetes, Nutrition and Endocrinology Department, Avicenne Hospital, Bobigny, France
    Obes Surg 22:403-10. 2012
    ..The aim of the present study was to evaluate the prevalence and the association of functional digestive symptoms affecting the upper and the lower digestive tract in patients eligible for bariatric surgery...